Last reviewed · How we verify
BALAFILCON A
At a glance
| Generic name | BALAFILCON A |
|---|---|
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
- Mild Punctate Keratitis
- Torticollis
Key clinical trials
- Short-Term Evaluation of Corneal Staining With Balafilcon A Lenses and Two Multi-Purpose Solutions (NA)
- Air Optix® Night and Day® Aqua Therapeutic Wear
- Air Optix® Night and Day® Aqua Continuous Wear
- Air Optix® Night and Day® Aqua Daily Wear
- A Clinical Study Comparing the Comfort of Three Commercially Available Contact Lenses (NA)
- Three Daily Wear Monthly Replacement Silicone Hydrogel Contact Lenses With Two Multi-purpose Disinfecting Solution Combinations (NA)
- Clinical Biocompatibility Evaluation of Contact Lens Coatings (NA)
- Ocular Responses to Short and Long-term Lens Wear (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- BALAFILCON A CI brief — competitive landscape report
- BALAFILCON A updates RSS · CI watch RSS